online games meaning

online games meaning Video: Car plunges into lake in Bhuvanagiri in Telangana, two rescuedJon Coupal: The Gann Limit is back in the newsSun Tzu, A Chinese military general, strategist, and philosopher who lived approximately in the 5th Century BC, is best known for his famous book 'The Art Of War'. In it, he wrote a proverb well-known to the world even today - "Keep your friends close, but your enemies closer". US President-elect Donald Trump seems to have taken a leaf out of Sun Tzu's book when he invited Chinese President Xi Jinping to his inaugural ceremony in Washington DC scheduled for January 20th. President Xi, who perhaps is also familiar with Sun Tzu works, read right through Donald Trump's invite and has politely declined it, as per the latest reports. Donald Trump's unprecedented decision to invite the Chinese President astonished officials in Washington and many others beyond. "A foreign leader has never attended the inauguration of a US President," said the US State Department after hours of looking up official records dating back to 1874. "It is, however, common for Ambassadors and other diplomats to attend the President's swearing-in ceremony," the US State Department added. Amid all the hustle and bustle at the White House - and chaos behind the scenes - Donald Trump's spokesperson Karoline Leavitt decided to give an interview to Fox News. Confirming the invite to Xi Jinping, Ms Leavitt said "This is an example of President Trump creating an open dialogue with leaders of countries that are not just allies but our adversaries and our competitors too." She also said that an invite for Donald Trump's oath taking ceremony was sent to several other foreign leaders besides just Xi Jinping, but did not reveal who they were. It is not known yet if these "other invites" were sent on the same day as the one extended to Xi Jinping, or after Washington learnt about the Chinese President's decision not to attend. Meanwhile, on the other side of the planet, officials in Beijing have remained tight-lipped over the issue. President Xi though, had, as recently as Tuesday, warned Washington about the expected tariff, trade, and tech wars once Trump becomes President. Expecting economic trouble in the weeks and months ahead, President Xi held a crucial meeting with heads of 10 major international organisations, including the World Bank, the International Monetary Fund, and World Trade Organisation (WTO) in Beijing. " There will be no winners ," he cautioned the United States in his speech at that meeting while he spoke about tariff hikes, tech-bans, and trade clampdowns that Donald Trump has vowed to impose on China once he takes charge. With such war of words and aggressive posturing by both Trump and Xi, the former's decision to invite the Chinese President for his inauguration ceremony does indeed seem both misplaced and rather unusual. Donald Trump has blown hot and cold in his views about Xi Jinping - calling him "a brilliant guy" on one occasion, and describing him as his nemesis on another. An invite sent, as one would, to an ally, on the one hand, and calling China "the greatest threat" on the other. Speaking about President Xi in his pre-election podcast with Joe Rogan, Trump had said, "He controls 1.4 billion people with an iron fist. I mean, he's a brilliant guy, whether you like it or not." But in two other interviews he called Xi Jinping the "biggest threat to the world" and labelled China as the "threat of the century". Donald Trump has also appointed Marco Rubio as his Secretary of State and Mike Walz as his National Security Adviser - both staunch critics of China who have kept a hawk's eye on every move Beijing makes - so much so, that the Chinese government has placed sanctions on Marco Rubio, and in 2020 had banned him from ever entering the country again - something Beijing would need to reconsider when he takes office as Secretary of State. Weeks before the Trump Administration takes over, NSA-designate Mike Waltz has already urged President-elect Trump to "urgently end the conflicts in Ukraine and the Middle East in order to counter the greater threat from the Chinese Communist Party". All eyes are now on what will be Trump's next move after the invitation snub, and what will be Xi Jinping's counter. The endgame is far from sight. Track Latest News Live on NDTV.com and get news updates from India and around the world

2024: Year when Bengaluru faced severe water crisis and recurring floods

THE Philippine Stock Exchange's (PSE) acquisition of a controlling stake in Philippine Dealing System Holdings Corp. (PDS) will boost confidence in the domestic capital market, analysts said. The PSE announced late Thursday that it had signed agreements to purchase a total of 3.87 million PDS shares worth P2.32 billion, equivalent to a 61.92-percent stake, that would add to an existing 20.98-percent interest. Register to read this story and more for free . Signing up for an account helps us improve your browsing experience. OR See our subscription options.

It’s no secret that San Franciscans don’t feel particularly great about their city government. Residents have repeatedly signaled in surveys that they feel The City is heading in the wrong direction , and November’s election saw candidates promising change earn voters’ support. But feelings aside, just how effective is city government, and is it meeting its own goals? The City Controller’s Office asks these questions every year and assembles a plethora of data to grade city departments. On Thursday, the Controller’s Office released its Annual Performance Results report, which features data from the fiscal year from July 2023 through June 2024. The goal is to not only provide San Franciscans with a snapshot of government performance, but help departments make decisions based on real data. “Good data informs good policy. We aim to provide something that’s a useful snapshot of our city’s service delivery performance — something to supplement the narratives that don’t always capture a complete picture of complicated issues,” Controller Greg Wagner said in a statement. “Departments can hopefully see at a glance what’s working well and where there’s more work to be done.” The Examiner pored over the report and highlighted a few noteworthy nuggets below. Libraries Maybe it’s just a symptom of bookflation , but the San Francisco Public Library has never been busier. The library system lent out about 14 million materials, which includes electronic and physical items, in the last fiscal year. That’s beyond the quantity in any other year in the last decade, and a pronounced recovery from a COVID-19 pandemic drop-off. The library system took steps during the pandemic to make electronic materials easier to access. It’s also seeing a rise in physical media distribution, which was up 12% last year, which is partly attributed to a change in policy that allowed patrons to renew physical materials for up to five times instead of three. ( Editor’s note: This is especially handy for items like cookbooks. Get comfortable, “The Levantine Vegetarian” by Salma Hage, you’re staying a while.) The circulation increase comes despite the fact that the number of physical people entering a physical library remains less than two-thirds of what it was prior to the pandemic, though even that figure continues to rise every year since COVID-safety restrictions were lifted. The jails Both violent and property crime continued to trend downward in San Francisco, but its jails are more full than in any other year included in the controller’s analysis. The average daily jail population in San Francisco rose by 34% from fiscal year 2023 to 2024, and its jails were at 86% of their rated capacity. The change is likely due to a couple of factors. The City joined up with state and federal law enforcement in May 2023 to launch a coordinated crackdown on low- and high-level drug dealing in and around the Tenderloin and Civic Center, where open-air drug markets had become commonplace. The jail population also began to rise after a pandemic-induced dropoff. Prior to 2020, the number of people in jail was above what it is now — 1,322 in fiscal year 2019, compared to the 1,099 on average for the last year — although capacity was higher at the time. 911 response A shortage of emergency dispatchers continues to plague The City’s 911 call-response times. In August, KQED reported The City is short about 40 dispatchers of its goal of 160 to 165. Just 76% of 911 calls were responded to within 15 seconds in fiscal year 2024. This was the fourth consecutive year in which response times worsened, according to the controller’s data. As recently as 2020, 94% of 911 calls were answered within 15 seconds. City data for the current fiscal year shows a moderate improvement within the last few months, with 82% of 911 calls answered within 15 seconds in September. San Francisco dispatchers not matched that monthly average response time in more than two years. The controller’s report attributes worsening performance to a shortage in staffing exacerbated by the COVID-19 pandemic, but it notes causes for hope. The Department of Emergency Management told the controller’s office that it has hired a recruiter and shortened its hiring process by 20%. Its last two 911 Dispatch Academy classes were its largest since prior to the pandemic and officials expect staffing to improve throughout the next fiscal year. Despite the dispatcher shortage, emergency responders were able to dramatically improve their response times to “A” emergencies — the most extreme situations — by nearly a full minute, from 6.9 last year to 6 this year. That’s significantly under the target of 8 minutes. Naloxone distribution After an alarming and steep increase in fatal opioid overdoses in recent years, city health officials have touted a steady dropoff throughout this year. One factor in the improvement may be The City’s drastic escalation in its distribution of naloxone, a drug that can reverse overdoses. Though it still fell short of its target for the year, the Department of Public Health reported giving out 157,528 doses of naloxone in fiscal year 2024, more than twice what it did just two years prior. The Examiner’s Evan Wyloge contributed data visualizations to this story.4 Tennis Stars Who Attended the Abu Dhabi GP Ft. Aryna Sabalenka

Eversource Energy (NYSE:ES) Shares Purchased by Empowered Funds LLCWomen's Top 25 roundup: No. 23 Michigan fends off NorthwesternJMP Securities lowered shares of Innovid ( NYSE:CTV – Free Report ) from an outperform rating to a market perform rating in a research report report published on Thursday morning, MarketBeat.com reports. Separately, Needham & Company LLC reaffirmed a “buy” rating and issued a $3.00 price target on shares of Innovid in a research note on Wednesday, November 13th. Four research analysts have rated the stock with a hold rating, According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $2.83. Read Our Latest Stock Report on Innovid Innovid Stock Performance Institutional Investors Weigh In On Innovid Several institutional investors and hedge funds have recently modified their holdings of CTV. Vanguard Group Inc. raised its holdings in Innovid by 6.5% during the first quarter. Vanguard Group Inc. now owns 4,555,974 shares of the company’s stock valued at $11,344,000 after buying an additional 279,830 shares in the last quarter. Royce & Associates LP increased its holdings in shares of Innovid by 5.4% during the 3rd quarter. Royce & Associates LP now owns 4,376,721 shares of the company’s stock valued at $7,878,000 after acquiring an additional 223,940 shares during the last quarter. Whetstone Capital Advisors LLC lifted its holdings in Innovid by 0.7% in the 3rd quarter. Whetstone Capital Advisors LLC now owns 3,268,879 shares of the company’s stock worth $5,884,000 after purchasing an additional 23,642 shares during the last quarter. Geode Capital Management LLC boosted its position in Innovid by 8.2% during the third quarter. Geode Capital Management LLC now owns 2,433,158 shares of the company’s stock worth $4,380,000 after purchasing an additional 184,309 shares during the period. Finally, State Street Corp grew its holdings in Innovid by 12.6% during the third quarter. State Street Corp now owns 1,188,183 shares of the company’s stock valued at $2,139,000 after purchasing an additional 133,281 shares during the last quarter. Institutional investors and hedge funds own 25.46% of the company’s stock. About Innovid ( Get Free Report ) Innovid Corp. operates an independent software platform that provides ad serving, measurement, and creative services. It offers advertising services for the creation, delivery, and measurement of TV ads across connected TV, mobile TV, and desktop TV environments to advertisers, publishers, and media agencies. Further Reading Receive News & Ratings for Innovid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovid and related companies with MarketBeat.com's FREE daily email newsletter .

Intelligence blended with wisdom needed to face challenges of changing world: Vice-Chancellor of Rani Channamma University

PM Wong’s speech a call for activists to go beyond grassroots work and explain policies: Observers

The Kraken were 0-3 at Madison Square Garden in the franchise’s three-year history, until they turned the game upside down in the second period Sunday afternoon. It was a 20-minute span in the Kraken’s eventual 7-5 win that saw Seattle score four times on 11 total shots. Everything seemed to end up in the back of the Rangers net, but a multitude of turnovers and breakdowns exacerbated the situation and carried over into the third period. “The goals were the chances, that was it,” head coach Peter Laviolette said. “We had the pieces in place and when it came down to the point where it had to be defended, it got loose. Definitely not what you’re looking for, you’re in charge of a game 3-1 and like I said, the chances were the goals. We could’ve been tighter and better in those situations.” The Kraken swarmed around the Rangers net on Brandon Tanev’s 3-2 score at the 14:06 mark of the middle frame. Less than a minute and a half later, the middle of the Rangers zone was exposed on Eeli Tolvanen’s goal. There wasn’t much to be done about Oliver Bjorkstand’s second goal of the game — a net-front deflection off a Brandon Montour shot — which gave the Kraken their first lead of the night at the end of the second. But it bled into the final frame, with a long-range one-timer from Vince Dunn finding its way past Rangers goalie Jonathan Quick before the Kraken slipped behind the Rangers D on Shane Wright’s 6-3 score. “The scoreboard and the goals,” Laviolette said of the switch. “If you go back and look at it, the chances — all of them — were the goals. So at those points in the game, we needed to defend better than what we did. We had the pieces in place, it was a little bit too loose and that looseness cost us.” Igor Shesterkin’s wife went into labor with their second child on Sunday, so the star Rangers netminder did not dress against the Kraken in what has already been an eventful week after signing an NHL-record contract for a goaltender . “He’s proven to be one of the top goaltenders,” Laviolette said. “To take such an important piece on our team and secure that piece for eight years is really reassuring. You think about sports in general, there’s really important positions and when it comes to hockey, goaltending is one of them. We’re fortunate to have one of the better ones.” As a result, the Rangers recalled Dylan Garand from AHL Hartford to backup Quick. Connor Mackey was also brought up to serve as an extra defenseman after Matthew Robertson was returned to the Wolf Pack on Saturday.

VANCOUVER, British Columbia, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “ Company ”, “ Rakovina ”, or “ Rakovina Therapeutics ”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies is pleased to announce the closing of a $3.0 million private placement. The private placement consists of 50,000,000 units (the “ Units ”) at a price of $0.06 per Unit. Each Unit consists of one common share of the Company (each, a “ Common Share ”) and one Common Share purchase warrant (each, a “ Warrant ”). Each Warrant entitles the holder thereof to subscribe for and purchase one Common Share of the Company for a period of 24 months from the date of issue at a price of $0.10 per Common Share. Rakovina retains the right to accelerate the Warrant exercise period if, upon written notice to the holder, the 20-day volume-weighted average price of its Common Shares exceeds $0.30. In connection with the Private Placement, the Company paid cash finder’s fees to Canaccord Genuity Corp., Ventum Financial Corp., Haywood Securities Inc., Research Capital Corporation, Hampton Securities Limited, Ewing Morris & Co. Investment Partners Ltd. and Leede Financial Inc. (each a “ Finder ”, and collectively, the “ Finders ”) in the aggregate amount of $180,841 and issued a total of 3,021,872 non-transferable finder’s warrants (each, a “ Finder’s Warrant ’) to the Finders, in accordance with the policies of the TSX Venture Exchange (the “ TSXV ”). Each Finder’s Warrant entitles the holder thereof to subscribe for and purchase one Common share of the Company for a period of 24 months from the date of issue at a price of $0.10 per Common Share, subject to acceleration on the same terms as the Warrants issued in connection with the private placement. The private placement is subject to the final acceptance of the TSXV and all securities issuable in connection with the private placement are subject to a hold period of four months plus one day from the date of issuance, in accordance with applicable securities laws. The proceeds of the private placement will be used to accelerate both discovery and development of the Company’s proprietary drug candidates, shortlisted from the Deep Docking and Variational AI platforms. “This overwhelming response from our investors underscores the strength of our science, the extraordinary talent and dedication of our team and the transformative potential of our therapies,” said Jeffrey Bacha, Executive Chairman of Rakovina Therapeutics. “We are deeply grateful for the trust placed in us and remain resolute in our mission to utilize leading AI technologies to develop innovative solutions for cancer care.” The Company extends its heartfelt thanks to its investors, partners, and team for their unwavering support as Rakovina continues its work to bring new hope to patients and families affected by cancer. Rakovina is pleased to announce its engagement of Fairfax Partners Inc. as its Investor Relations (IR) partner. With extensive expertise in investor engagement strategies, Fairfax will implement a comprehensive six-month IR program designed to enhance Rakovina’s market presence and expand its investor base. The program, which includes an option to renew for an additional six months, focuses on complementing traditional IR efforts with targeted online marketing campaigns, activation of a robust social media influencer network, and collaboration with external consultants and global wealth management channels. These initiatives will support Rakovina’s strategic plan for 2025 by institutionalizing its investor base and strengthening its distribution capabilities. Under the agreement, Fairfax will receive a monthly fee of $5,000 plus GST, a one-time setup fee of $15,000 plus GST, and a marketing budget of $120,000 plus GST, disbursed as follows: $80,000 upon signing and $40,000 two months later. Services provided by Fairfax include inbound and outbound phone communications, website and social media management, marketing material preparation, news release support, and roadshow assistance, ensuring Rakovina’s IR efforts align with market expectations. Fairfax Partners Inc., located at 306-1238 Seymour Street, Vancouver, BC, confirms that neither its directors nor officers hold any securities of Rakovina. For inquiries, please contact connect@fairfaxpartners.com. “We are thrilled to partner with the seasoned team at Fairfax Partners to expand our investor base and increase awareness of Rakovina Therapeutics’ vision. Fairfax’s creative and forward-thinking approach to investor relations will be a critical asset as we enter a pivotal year. By harnessing their extensive network and digital expertise, we aim to significantly enhance our market presence and deliver lasting value to our shareholders,” said Mr. Bacha. About Rakovina Therapeutics Inc. Rakovina Therapeutics Inc. is dedicated to developing innovative cancer therapies targeting the DNA-damage response. The company has established a development pipeline of novel DNA-damage response inhibitors by leveraging Artificial Intelligence (AI) to accelerate the identification and optimization of drug candidates. Rakovina Therapeutics aims to advance one or more of these candidates into human clinical trials in collaboration with pharmaceutical partners and secure marketing approvals from Health Canada, the U.S. Food and Drug Administration, and other international regulatory agencies. Further information may be found at www.rakovinatherapeutics.com . The TSXV has neither approved nor disapproved the content of this press release. Neither the TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. Notice Regarding Forward-Looking Statements: This release includes forward-looking statements regarding the Company and its respective business, which may include, but is not limited to, statements with respect to the terms of the private placement, the closing of the private placement, the receipt of final TSXV approval, the proposed business plan of the Company; the Company’s commitment to advancing new cancer therapies; the ability of the Company to extract value from its AI collaborations; the Company’s ability to execute on its business plans while maintaining high standards of research; the ability of Pharma Inventor Inc. to accurately provide medicinal chemistry support; the projected timeline and effectiveness of the Company’s strategy to utilize the Deep Docking AI platform; and the Company’s ability to generate shareholder value. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “is expected”, “expects”, “scheduled”, “intends”, “contemplates”, “anticipates”, “believes”, “proposes” or variations (including negative variations) of such words and phrases, or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such statements are based on the current expectations of the management of the Company. The forward-looking events and circumstances discussed in this release may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including risks regarding the medical device industry, economic factors, regulatory factors, the equity markets generally and risks associated with growth and competition. Although the Company has attempted to identify important factors that could cause actual actions, events, or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events, or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. The reader is referred to the Company’s most recent filings on SEDAR for a more complete discussion of all applicable risk factors and their potential effects, copies of which may be accessed through the Company’s profile page at www.sedar.com. For Further Information Contact: David Hyman, Chief Financial Officer info@rakovinatherapeutics.com Invest Relations &Media Michelle Seltenrich ir@rakovinatherapeutics.com 778-773-5432

KUWAIT: Gulf Bank has organized the “Movember” campaign to further its commitment to employee health and well-being, following the success of Breast Cancer Awareness Month in October. Celebrated globally in November, this initiative focuses on raising awareness about men’s health, with an emphasis on important issues like prostate cancer and mental health. The campaign offered male employees initial medical screenings for prostate cancer and mental health assessments, conducted in partnership with Royale Hayat Hospital and MindWell Clinic. Gulf Bank remains dedicated to fostering a work environment that supports overall well-being, with a strong focus on health. This initiative aligns with the Bank’s sustainability strategy, which aims to promote a comprehensive approach to employee welfare. Prior to launching the “Movember” campaign, Gulf Bank organized a health and wellness initiative for female employees, which included various health, awareness, and sports activities. This initiative highlights the Bank’s commitment to nurturing and empowering its workforce, recognizing both male and female employees as its most valuable assets. These activities are part of the wide range of initiatives Gulf Bank implements each year as part of its sustainability programs, addressing key community issues. These programs are inclusive, supporting employees of all genders and people of determination. Gulf Bank recognizes its essential role in promoting public health, particularly among its employees. The “Movember” campaign provides an opportunity to involve the broader community in meaningful conversations about men’s health, which is often overlooked. The Bank aims for this campaign to inspire positive behavior changes and bring greater focus to men’s overall health and well-being. Gulf Bank is dedicated to upholding sustainability principles by promoting gender equality, providing fair benefits to all employees, and implementing sustainability standards both internally and externally. This commitment reinforces the Bank’s leadership position in Kuwait. Gulf Bank aims to be Kuwait’s leading bank, fostering a diverse and inclusive workplace to deliver exceptional customer service while contributing sustainably to the community. Through its extensive branch network and innovative digital services, the bank empowers customers to conduct banking transactions conveniently and efficiently, ensuring a seamless experience. In alignment with Kuwait Vision 2035, “New Kuwait,” and its commitment to fostering collaborative partnerships, Gulf Bank is dedicated to driving robust sustainability initiatives across environmental, social, and governance (ESG) dimensions. The bank is committed to implementing strategically selected and diverse sustainability programs both internally and externally.The New England Patriots will take on the Los Angeles Chargers on Saturday afternoon at Gillette Stadium for their second-to-last game of the season. Ahead of the matchup, they downgraded center Ben Brown to out due to a concussion. Instead, New England will have to rely on either Cole Strange or Lecitus Smith, neither of who have ever played center in an NFL game, to man the middle of the offense line. New England also placed cornerback Marcus Jones on season-ending injured reserve with a hip injury. He finished his season with 58 tackles, 10 passes defensed and an interception while averaging a career-high 14.8 yards per punt return. This is the second year in a row that Jones' season ends early due to injury. To fill his spot on the roster, the Patriots activated tackle Caedan Wallace from injured reserve. He's been out since early October with an ankle injury, and if he's good to go, he could start at either left or right tackle for the final two games of the year. If Wallace plays well, he could solve an issue for the offseason. New England also elevated wide receiver/returner Alex Erickson and linebacker Montry Rice from the practice squad. Erickson made his Patriots debut in Week 16 against the Buffalo Bills, fielding one punt. Rice played in his first game with New England last week, playing 13 special teams snaps. MORE PATRIOTS NEWS Patriots keys to victory vs. Chargers Expert picks, predictions for Patriots vs. Chargers Patriots rule out 1, list 10 as questionable for Week 17 Kendrick Bourne is attempting to recruit stud wideout to New England